Objective: The purpose of this study was to compare the accuracy
of commonly used methods for the detection of rubella immunity, especially the fully
automated IMx assay.
Methods: A total of 190 sera (101 immune and 89 non-immune)
submitted to Harrisburg Hospital or Polyclinic Medical Center for the determination of
rubella immunity were tested by enzyme immunoassay (IMx and Rubazyme, Abbott
Diagnostic Laboratories, North Chicago, IL), indirect immunofluorescence (FIAX, Whittaker
Bioproducts, Walkersville, MD), and latex agglutination (Rubascan, Becton Dickinson
Microbiology Systems, Cockeysville, MD, and Rubalex, Wellcome Diagnostics, Research
Triangle Park, NC). Specimens were frozen at â30â until the study was initiated. Each of
the assays was performed according to the manufacturers' specifications. Sensitivity,
specificity, accuracy, and positive and negative predictive values for each assay were
calculated using a consensus result of the 5 methods tested.
Results: The sensitivity, specificity, and accuracy, respectively, of the
test systems were as follows: IMx, 96%, 97%, and 96%; Rubazyme, 100%, 99%, and 99%;
Rubascan, 100%, 98%, and 99%; Rubalex, 99%, 97%, and 98%; and FIAX 90%, 100%, and
95%. False negative reactions were seen with the FIAX system.
Conclusions: The IMx system, a new âwalk awayâ system from Abbott
Diagnostic Laboratories and the Rubazyme systems performed well; however the latex
agglutination tests proved to be the most rapid and convenient methods for screening
sera for the presence of rubella immunity.